105 related articles for article (PubMed ID: 30477387)
21. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
22. Predictors of colorectal cancer screening: a comparison of men and women.
McGregor SE; Bryant HE
Can J Gastroenterol; 2005 Jun; 19(6):343-9. PubMed ID: 15997267
[TBL] [Abstract][Full Text] [Related]
23. Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.
Sanford NN; Sher DJ; Butler S; Xu X; Ahn C; D'Amico AV; Rebbeck T; Aizer AA; Mahal BA
JAMA Netw Open; 2019 May; 2(5):e193759. PubMed ID: 31099863
[TBL] [Abstract][Full Text] [Related]
24. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.
Ruffin MT; Gorenflo DW; Woodman B
J Am Board Fam Pract; 2000; 13(1):1-10. PubMed ID: 10682879
[TBL] [Abstract][Full Text] [Related]
25. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
26. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
27. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
[TBL] [Abstract][Full Text] [Related]
28. Are there gender differences in colorectal cancer test use prevalence and correlates?
McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
[TBL] [Abstract][Full Text] [Related]
29. Comparison of endoscopic procedures for colorectal cancer screening in women with mammography and Pap smear.
Nicholson FB; Korman MG
Gastrointest Endosc; 2004 Sep; 60(3):400-7. PubMed ID: 15332031
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
[TBL] [Abstract][Full Text] [Related]
31. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
[TBL] [Abstract][Full Text] [Related]
32. Alcohol consumption and rates of cancer screening: Is cancer risk overestimated?
Mu L; Mukamal KJ
Cancer Causes Control; 2016 Feb; 27(2):281-9. PubMed ID: 26590914
[TBL] [Abstract][Full Text] [Related]
33. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
34. Sex-based disparities in colorectal cancer screening.
Yager SS; Chen L; Cheung WY
Am J Clin Oncol; 2014 Dec; 37(6):555-60. PubMed ID: 23466582
[TBL] [Abstract][Full Text] [Related]
35. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
Charkhchi P; Schabath MB; Carlos RC
J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
[TBL] [Abstract][Full Text] [Related]
36. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
[TBL] [Abstract][Full Text] [Related]
37. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
[TBL] [Abstract][Full Text] [Related]
38. Associations in breast and colon cancer screening behavior in women.
Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
[TBL] [Abstract][Full Text] [Related]
39. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
Olynyk JK; Platell CF; Collett JA
J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
[TBL] [Abstract][Full Text] [Related]
40. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
